二甘醇代谢物二甘醇酸在大鼠体内的肾毒性和肝功能改变证据
二甘醇酸(DGA)是二甘醇(DEG)的两个主要代谢物之一,DEG工业溶剂误用曾导致急性肾损伤、肝毒性、脑病和外周神经病变为特征的大规模中毒。本研究将成年雄性Wistar大鼠分为0、100、300 mg/kg DGA单次灌胃三组,收集尿液并于给药后48小时处死取血、肾和肝分析。结果显示仅300 mg/kg组DGA在肾和肝组织显著蓄积,且蓄积浓度分别与肾损伤和肝损伤相关;组织病理和临床化学分析显示仅300 mg/kg组出现中度肝脂肪蓄积和明显肾损伤。作者认为DGA直接给药可在体内产生毒性,陡峭的剂量反应阈值提示存在可饱和步骤导致DGA在靶器官蓄积。
要点
- 成年雄性Wistar大鼠单次口服DGA 300 mg/kg后肾和肝组织显著蓄积DGA,且蓄积浓度分别与肾损伤和肝损伤相关。
- 仅300 mg/kg组出现明显肾损伤和中度肝脂肪蓄积;100 mg/kg组未观察到毒性,提示陡峭剂量反应阈值。
- DGA是DEG的两个主要代谢物之一,DEG中毒以急性肾损伤、肝毒性、脑病和外周神经病变为特征。
- 该研究为动物体内实验,直接给予DGA,非人体数据,不能直接推导人体剂量阈值。
适用人群与场景
- 成年雄性Wistar大鼠,单次经口灌胃给予DGA 0、100或300 mg/kg,给药后48小时处死分析。
研究设计与关键结果
- 研究类型:动物体内实验;成年雄性Wistar大鼠分为0、100、300 mg/kg DGA单次口服灌胃三组。
- 仅300 mg/kg组DGA在肾和肝组织显著蓄积,肾和肝DGA浓度分别与肾损伤和肝损伤相关。
- 组织病理和临床化学分析显示仅300 mg/kg组出现中度肝脂肪蓄积和明显肾损伤;100 mg/kg组未观察到毒性。
- 给药后48小时处死取血、肾和肝分析,尿液每6-12小时收集一次。
证据类型、等级与局限
- 证据类型:动物体内实验(大鼠)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该研究为动物实验,结果提示DGA直接给药可在体内产生肾毒性和肝毒性,陡峭剂量反应阈值提示存在可饱和步骤导致DGA在靶器官蓄积;不能直接转化为人体急诊/ICU实践推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
CONTEXT: Diglycolic acid (DGA) is one of the two primary metabolites of diethylene glycol (DEG). DEG is an industrial solvent that has been implicated in mass poisonings resulting from product misuse in the United States and worldwide, with the hallmark toxicity being acute kidney injury, hepatotoxicity, encephalopathy and peripheral neuropathy. Our laboratory has generated in-vitro evidence suggesting that DGA is the metabolite responsible for the proximal tubule necrosis and decreased kidney function observed following DEG ingestion. Furthermore, we have shown that DGA specifically accumulates in kidney tissues (100× higher than peak blood concentrations) following DEG administration.
OBJECTIVE: To examine renal and hepatic accumulation and dysfunction following direct administration of DGA in-vivo. We hypothesize that administration of DGA will result in renal and hepatic DGA accumulation, as well as proximal tubular necrosis and liver injury.
MATERIALS AND METHODS: Adult male Wistar rats were divided into three groups dosed with 0, 100 or 300 mg/kg DGA via single oral gavage. Urine was collected every 6-12 h and blood, kidneys and liver were removed upon sacrifice at 48 h post-dosing for analysis.
RESULTS: DGA accumulated significantly in both kidney and liver tissue only at 300 mg DGA/kg. DGA concentrations in the kidneys and liver correlated with renal and hepatic injury, respectively. Histopathological and clinical chemistry analysis revealed that DGA-treated animals exhibited moderate liver fatty accumulation and marked renal injury, again only at 300 mg/kg.
DISCUSSION: DGA-induced kidney injury demonstrated a steep dose response threshold, where severe damage occurred only in animals given 300 mg/kg DGA, while no toxicity was observed at 100 mg/kg.
CONCLUSION: These results provide evidence for in-vivo toxicity following direct administration of DGA, a metabolite of DEG. The steep dose-response threshold for toxicity suggests mechanistically that there is likely a saturable step that results in DGA accumulation in target organs.
参考来源
- Robinson CN, Latimer B, Abreo F, et al. In-vivo evidence of nephrotoxicity and altered hepatic function in rats following administration of diglycolic acid, a metabolite of diethylene glycol. Clin Toxicol (Phila). 2017. PMID: 28074668. doi:10.1080/15563650.2016.1271128
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。